Cipta Sarana Medika Tbk. vs Mandiri Herindo Adiperkasa Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Mandiri Herindo Adiperkasa Tbk. trades at Rp140 (market cap 2.35T, 1.61M 24h volume). The key difference: Mandiri Herindo Adiperkasa Tbk. is far larger — about 14.9× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 1.61M). Which is the better fit depends on your goals.
| DKHH | MAHA | |
|---|---|---|
Market Cap | 158.12B | 2.35T |
Volume | 8.21M | 1.61M |
Lot | 82.15K | 16.07K |
Turnover | 515.2M | 224.77M |
Average Price | 62.72 | 139.86 |
Value | 515.2M | 224.77M |
Indicative Equilibrium Price | 63 | 140 |
Indicative Equilibrium Volume | 1.33K | 940 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Mandiri Herindo Adiperkasa Tbk. (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Julia Rochana Murat, S.H., No. 18 dated January 25, 1994. The Company started commercial activities in 1994.
Read more on MAHA →